Wednesday, April 25, 2012

Drugs firm takes cost conscious doctors to court - The Independent


John Harris, a professor of medical ethics at Manchester University, said companies such as Novartis should not be allowed to block attempts at using more cost-effective treatments to maximise their profits.

"It is legitimate for healthcare providers to appraise and approve off-label treatments which are significantly more cost-effective than those that pharma are prepared to licence," Professor Harris said.

Posted via email from Jack's posterous

No comments: